Glycomacropeptide Protects against Inflammation and Oxidative Stress, and Promotes Wound Healing in an Atopic Dermatitis Model of Human Keratinocytes
Author:
Gallegos-Alcalá Pamela1ORCID, Jiménez Mariela1ORCID, Cervantes-García Daniel12ORCID, Córdova-Dávalos Laura Elena1, Gonzalez-Curiel Irma3ORCID, Salinas Eva1ORCID
Affiliation:
1. Laboratory of Immunology, Department of Microbiology, Center of Basic Science, Universidad Autónoma de Aguascalientes, Av. Universidad # 940, Aguascalientes 20100, Mexico 2. National Council of Science and Technology, Av. de los Insurgentes Sur 1582, Crédito Constructor, Benito Juárez, Ciudad de México 03940, Mexico 3. Laboratory of Immunotoxicology and Experimental Therapeutics, Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Carr. Zac.-Gdl. Km 6, Zacatecas 98160, Mexico
Abstract
Keratinocytes are actively implicated in the physiopathology of atopic dermatitis (AD), a skin allergy condition widely distributed worldwide. Glycomacropeptide (GMP) is a milk-derived bioactive peptide generated during cheese making processes or gastric digestion. It has antiallergic and skin barrier restoring properties when it is orally administered in experimental AD. This study aimed to evaluate the effect of GMP on the inflammatory, oxidative, proliferative, and migratory responses of HaCaT keratinocytes in an in vitro AD model. GMP protected keratinocytes from death and apoptosis in a dose dependent manner. GMP at 6.3 and 25 mg/mL, respectively, reduced nitric oxide by 50% and 83.2% as well as lipid hydroperoxides by 27.5% and 45.18% in activated HaCaT cells. The gene expression of TSLP, IL33, TARC, MDC, and NGF was significantly downregulated comparably to control by GMP treatment in activated keratinocytes, while that of cGRP was enhanced. Finally, in an AD microenvironment, GMP at 25 mg/mL stimulated HaCaT cell proliferation, while concentrations of 0.01 and 0.1 mg/mL promoted the HaCaT cell migration. Therefore, we demonstrate that GMP has anti-inflammatory and antioxidative properties and stimulates wound closure on an AD model of keratinocytes, which could support its reported bioactivity in vivo.
Funder
Autonomous University of Aguascalientes Mexican National Council for Science and Technology, CONACYT
Subject
Plant Science,Health Professions (miscellaneous),Health (social science),Microbiology,Food Science
Reference63 articles.
1. Gallegos-Alcalá, P., Jiménez, M., Cervantes-García, D., and Salinas, E. (2021). The Keratinocyte as a Crucial Cell in the Predisposition, Onset, Progression, Therapy and Study of the Atopic Dermatitis. Int. J. Mol. Sci., 22. 2. Hadi, H.A., Tarmizi, A.I., Khalid, K.A., Gajdács, M., Aslam, A., and Jamshed, S. (2021). The Epidemiology and Global Burden of Atopic Dermatitis: A Narrative Review. Life, 11. 3. Epidemiology of Atopic Dermatitis in Adults: Results from an International Survey;Barbarot;Allergy,2018 4. Tsuge, M., Ikeda, M., Matsumoto, N., Yorifuji, T., and Tsukahara, H. (2021). Current Insights into Atopic March. Children, 8. 5. Global Burden, Incidence and Disability-Adjusted Life-Years for Dermatitis: A Systematic Analysis Combined with Socioeconomic Development Status, 1990–2019;Xue;Front. Cell. Infect. Microbiol.,2022
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|